66 results
8-K
EX-1.1
NRIX
Nurix Therapeutics Inc
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
such information furnished by any Underwriter consists of the information described as such in Section 7(b) hereof.
(d) Testing-the-Waters Materials
424B5
NRIX
Nurix Therapeutics Inc
12 Apr 24
Prospectus supplement for primary offering
5:10pm
information” for information concerning how to obtain copies of materials that we file with the SEC.
Any statement contained in this prospectus … of materials that we file with the SEC.
Any statement contained in this prospectus, or in a document, all or a portion of which is incorporated
424B5
NRIX
Nurix Therapeutics Inc
11 Apr 24
Prospectus supplement for primary offering
4:06pm
concerning how to obtain copies of materials that we file with the SEC.
Any statement contained in this prospectus supplement and the accompanying … ” for information concerning how to obtain copies of materials that we file with the SEC.
Any statement contained in this prospectus, or in a document
DEFA14A
NRIX
Nurix Therapeutics Inc
27 Mar 24
Additional proxy soliciting materials
7:02am
Definitive Additional Materials
Soliciting Material Pursuant to §240.14a-12
NURIX THERAPEUTICS, INC.
(Name of Registrant as Specified in Its Charter)
N … paid previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
8-K
rvdb q1358z25dn
8 Jan 24
Regulation FD Disclosure
7:03am
8-K
EX-3.1
vmdk18tpu cn
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
zgc2ne ifp6ors
12 Dec 22
Other Events
5:36pm
8-K
EX-10.1
dz5sv4e ztggc
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm